Karolin Hansén Hallor

Karolin Hansén Hallor

Auto-generated profile, based on publicly available information

Karolin Hansén Hallor

Lund University

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 November 2011 in Nature Genetics
Verified
Journal Article
Open access
PDF file
TPTwinkal C Pansuriya
Twinkal C Pansuriya
RERonald van Eijk
Ronald van Eijk
ADAdamo Pio d'Adamo
Adamo Pio d'Adamo
MRMaayke A J H van Ruler
Maayke A J H van Ruler
Marieke KuijjerMarieke Kuijjer
Marieke Kuijjer
Judith V.M.G. BovéeJudith V.M.G. Bovée
Judith V.M.G. Bovée
Judith Bovée and colleagues report the identification of somatic mosaic mutations in IDH1 and IDH2 in tumors from individuals with Ollier disease and Maffucci syndrome, which are non-hereditary skeletal disorders characterized by multiple enchondromas. Ollier disease and Maffucci syndrome are non-hereditary skeletal disorders characterized by multiple enchondromas (Ollier disease) combined with spindle cell hemangiomas (Maffucci syndrome). We report somatic heterozygous mutations in IDH1 (c.394C>T encoding an R132C substitution and c.395G>A encoding an R132H substitution) or IDH2 (c.516G>C encoding R172S) in 87% of enchondromas (benign cartilage tumors) and in 70% of spindle cell hemangiomas (benign vascular lesions). In total, 35 of 43 (81%) subjects with Ollier disease and 10 of 13 (77%) with Maffucci syndrome carried IDH1 (98%) or IDH2 (2%) mutations in their tumors. Fourteen of 16 subjects had identical mutations in separate lesions. Immunohistochemistry to detect mutant IDH1 R132H protein suggested intraneoplastic and somatic mosaicism. IDH1 mutations in cartilage tumors were associated with hypermethylation and downregulated expression of several genes. Mutations were also found in 40% of solitary central cartilaginous tumors and in four chondrosarcoma cell lines, which will enable functional studies to assess the role of IDH1 and IDH2 mutations in tumor formation.

12 June 2013 in Genes, Chromosomes and Cancer
Verified
Journal Article
Closed access
PDF file
AMArezoo Mohajeri
Arezoo Mohajeri
JTJohnbosco Tayebwa
Johnbosco Tayebwa
ACAnna Collin
Anna Collin
JNJenny Nilsson
Jenny Nilsson
LMLinda Magnusson
Linda Magnusson
FMFredrik Mertens
Fredrik Mertens

29 January 2014 in The Journal of Pathology
Verified
Journal Article
Closed access
PDF file
CWCharles Walther
Charles Walther
JTJohnbosco Tayebwa
Johnbosco Tayebwa
HLHenrik Lilljebjörn
Henrik Lilljebjörn
LMLinda Magnusson
Linda Magnusson
JNJenny Nilsson
Jenny Nilsson
FMFredrik Mertens
Fredrik Mertens

9 May 2005 in Genes, Chromosomes and Cancer
Verified
Journal Article
Closed access
PDF file
KHKarolin Hansén Hallor
Karolin Hansén Hallor
FMFredrik Mertens
Fredrik Mertens
YJYuesheng Jin
Yuesheng Jin
JMJeanne M. Meis‐Kindblom
Jeanne M. Meis‐Kindblom
LKLars‐Gunnar Kindblom
Lars‐Gunnar Kindblom
IPIoannis Panagopoulos
Ioannis Panagopoulos

1 June 2014 in American Journal of Surgical Pathology
Verified
Journal Article
Closed access
EAElsa Arbajian
Elsa Arbajian
FPFlorian Puls
Florian Puls
LMLinda Magnusson
Linda Magnusson
KTKhin Thway
Khin Thway
CFCyril Fisher
Cyril Fisher
FMFredrik Mertens
Fredrik Mertens
Sclerosing epithelioid fibrosarcoma (SEF) and low-grade fibromyxoid sarcoma (LGFMS) are 2 distinct types of sarcoma, with a subset of cases showing overlapping morphologic and immunohistochemical features. LGFMS is characterized by expression of the MUC4 protein, and about 90% of cases display a distinctive FUS-CREB3L2 gene fusion. In addition, SEF is often MUC4 positive, but is genetically less well studied. Fluorescence in situ hybridization (FISH) studies have shown involvement of the FUS gene in the majority of so-called hybrid LGFMS/SEF and in 10% to 25% of sarcomas with pure SEF morphology. In this study, we investigated a series of 10 primary tumors showing pure SEF morphology, 4 cases of LGFMS that at local or distant relapse showed predominant SEF morphology, and 1 primary hybrid LGFMS/SEF. All but 1 case showed diffuse expression for MUC4. Using FISH, reverse transcription polymerase chain reaction, and/or mRNA sequencing in selected cases, we found recurrent EWSR1-CREB3L1 fusion transcripts by reverse transcription polymerase chain reaction in 3/10 pure SEF cases and splits and deletions of the EWSR1 and/or CREB3L1 genes by FISH in 6 additional cases. All 5 cases of LGFMS with progression to SEF morphology or hybrid features had FUS-CREB3L2 fusion transcripts. Our results indicate that EWSR1 and CREB3L1 rearrangements are predominant over FUS and CREB3L2 rearrangements in pure SEF, highlighting that SEF and LGFMS are different tumor types, with different impacts on patient outcome.

15 February 2012 in Genes, Chromosomes and Cancer
Verified
Journal Article
Closed access
PDF file
YJYuesheng Jin
Yuesheng Jin
EMEmely Möller
Emely Möller
KNKarolin H. Nord
Karolin H. Nord
NMNils Mandahl
Nils Mandahl
FSFredrik Vult Von Steyern
Fredrik Vult Von Steyern
FMFredrik Mertens
Fredrik Mertens